![Mark Lappe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lappe
Keine laufenden Positionen mehr
Vermögen: 96 Mio $ am 31.05.2026
Profil
Mark Paul Lappe is the founder of Lappe & Associates, Inc. (1990).
Mr. Lappe is the founder of Efficacy Capital LLC (2004).
Mr. Lappe is the founder of Inhibrx LP (2010).
Mr. Lappe is the founder of Sanofi AATD, Inc. (2010).
Mr. Lappe is also the founder of Efficacy Biotech Fund LP.
Mr. Lappe is currently the Chairman & Chief Executive Officer at Inhibrx Biosciences, Inc. since 2025.
Mr. Lappe is currently the Managing Partner at Efficacy Capital Ltd. since 2003.
Formerly, Mr. Lappe served as Chairman at Repros Therapeutics, Inc. from 2008 to 2009.
Mr. Lappe served as Non-Executive Director at Osmetech Ltd. in 2009.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
6.31% | 07.04.2026 | 925’413 ( 6.31% ) | 96 Mio $ | 31.05.2026 |
Aktive Positionen von Mark Lappe
| Unternehmen | Position | Beginn |
|---|---|---|
Efficacy Capital Ltd. | Corporate Officer/Principal | 10.06.2009 |
Ehemalige bekannte Positionen von Mark Lappe
| Unternehmen | Position | Ende |
|---|---|---|
| INHIBRX, INC. | Vorstandsvorsitzender | 30.05.2024 |
| REPROS THERAPEUTICS INC | Vorsitzender | 12.11.2009 |
Osmetech Ltd.
 Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Direktor/Vorstandsmitglied | 28.08.2009 |
Efficacy Biotech Fund LP | Gründer | - |
Inhibrx LP
 Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat hormonal and reproductive system disorders | Health Technology |
Efficacy Capital Ltd. | |
Efficacy Biotech Fund LP | |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Health Services |
Lappe & Associates, Inc. | |
Efficacy Capital LLC
 Efficacy Capital LLC Investment ManagersFinance Efficacy Capital invests in US publicly-traded stocks and in fixed-income securities. The firm invests mainly in companies operating in the biotechnology and pharmaceutical industries. | Finance |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
